172 related articles for article (PubMed ID: 37581693)
41. Combination of hepatocellular markers is useful for prognostication in gastric hepatoid adenocarcinoma.
Osada M; Aishima S; Hirahashi M; Takizawa N; Takahashi S; Nakamura K; Tanaka M; Maehara Y; Takayanagi R; Oda Y
Hum Pathol; 2014 Jun; 45(6):1243-50. PubMed ID: 24767858
[TBL] [Abstract][Full Text] [Related]
42. Early Gastric Cancer with Purely Enteroblastic Differentiation and No Conventional Adenocarcinoma Component.
Yamada R; Horiguchi SI; Onishi T; Motoi T; Hishima T
Case Rep Pathol; 2018; 2018():3620293. PubMed ID: 30228922
[TBL] [Abstract][Full Text] [Related]
43. [Two cases of gastric cancer expressing Glypican 3, but producing AFP with different lectin affinity].
Oishi C; Baba T; Kubota Y; Shimotsuma Y; Kitamura K; Honma T; Ikegami A; Inokuchi M; Umeda T; Yoshida H; Imawari M
Nihon Shokakibyo Gakkai Zasshi; 2009 Jun; 106(6):805-12. PubMed ID: 19498312
[TBL] [Abstract][Full Text] [Related]
44. Carcinosarcoma of the stomach: four cases that expand the morphologic spectrum of gastric cancer with a primitive phenotype.
Yamazawa S; Ushiku T
Virchows Arch; 2022 May; 480(5):1051-1062. PubMed ID: 35243539
[TBL] [Abstract][Full Text] [Related]
45. Alpha-fetoprotein-producing ovarian clear cell adenocarcinoma with fetal gut differentiation: a rare case report and literature review.
Chao WT; Liu CH; Lai CR; Chen YJ; Chuang CM; Wang PH
J Ovarian Res; 2018 Jun; 11(1):52. PubMed ID: 29933751
[TBL] [Abstract][Full Text] [Related]
46. High level of serum AFP is an independent negative prognostic factor in gastric cancer.
Chen Y; Qu H; Jian M; Sun G; He Q
Int J Biol Markers; 2015 Nov; 30(4):e387-93. PubMed ID: 26349668
[TBL] [Abstract][Full Text] [Related]
47. Clinicopathologic features of gastric cancers producing alpha-fetoprotein.
Kono K; Amemiya H; Sekikawa T; Iizuka H; Takahashi A; Fujii H; Matsumoto Y
Dig Surg; 2002; 19(5):359-65; discussion 365. PubMed ID: 12435906
[TBL] [Abstract][Full Text] [Related]
48. Alpha-fetoprotein-producing gastric carcinoma with enteroblastic differentiation.
Matsunou H; Konishi F; Jalal RE; Yamamichi N; Mukawa A
Cancer; 1994 Feb; 73(3):534-40. PubMed ID: 7507794
[TBL] [Abstract][Full Text] [Related]
49. Gastrointestinal Obstruction due to Solitary Lymph Node Recurrence of Alpha-Fetoprotein-Producing Gastric Carcinoma with Enteroblastic Differentiation.
Yamabuki T; Omi M; Yonemori A; Misu K; Inomata H; Abiko Y; Mori M; Nihei K
Case Rep Gastroenterol; 2014 Jan; 8(1):1-6. PubMed ID: 24574942
[TBL] [Abstract][Full Text] [Related]
50. α-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression.
Ikeda H; Sato Y; Yoneda N; Harada K; Sasaki M; Kitamura S; Sudo Y; Ooi A; Nakanuma Y
Hum Pathol; 2012 Nov; 43(11):1955-63. PubMed ID: 22516245
[TBL] [Abstract][Full Text] [Related]
51. Gallbladder's Adenocarcinoma With Enteroblastic Differentiation Revealed by 18 F-FDG PET/CT.
Cui Y; Liu Y; Du B; Li Y; Li X
Clin Nucl Med; 2024 Mar; 49(3):258-259. PubMed ID: 38271224
[TBL] [Abstract][Full Text] [Related]
52. An unusual primary malignant tumor of the stomach: fetal gutlike gastric adenocarcinoma with "blastoma"-like component.
Taher A; Denic N; Kalimuthu SN; Chetty R
Hum Pathol; 2017 Sep; 67():176-180. PubMed ID: 28315695
[TBL] [Abstract][Full Text] [Related]
53. A case of adenocarcinoma with enteroblastic differentiation of the ampulla of Vater.
Mitsuma K; Taniguchi H; Kishi Y; Hiraoka N
Pathol Int; 2016 Apr; 66(4):230-5. PubMed ID: 27016918
[TBL] [Abstract][Full Text] [Related]
54. Glypican 3-expressing gastric carcinoma: distinct subgroup unifying hepatoid, clear-cell, and alpha-fetoprotein-producing gastric carcinomas.
Ushiku T; Uozaki H; Shinozaki A; Ota S; Matsuzaka K; Nomura S; Kaminishi M; Aburatani H; Kodama T; Fukayama M
Cancer Sci; 2009 Apr; 100(4):626-32. PubMed ID: 19243386
[TBL] [Abstract][Full Text] [Related]
55. Rectal carcinoma with dual differentiation toward enteroblastic and neuroendocrine features arising in a patient with ulcerative colitis: a case report.
Kihara T; Kuwahara R; Kusunoki K; Minagawa T; Horio Y; Uchino M; Ikeuchi H; Hirota S
World J Surg Oncol; 2022 Nov; 20(1):371. PubMed ID: 36434637
[TBL] [Abstract][Full Text] [Related]
56. Histologic and immunohistochemical analyses of α-fetoprotein--producing cancer of the stomach.
Kinjo T; Taniguchi H; Kushima R; Sekine S; Oda I; Saka M; Gotoda T; Kinjo F; Fujita J; Shimoda T
Am J Surg Pathol; 2012 Jan; 36(1):56-65. PubMed ID: 22173117
[TBL] [Abstract][Full Text] [Related]
57. Outcomes of Third-Line Trastuzumab Deruxtecan in a Patient with De Novo Stage 4 HER2-Positive Gastric Adenocarcinoma with Enteroblastic Differentiation: A Case Report.
Ngan RK
Life (Basel); 2023 Aug; 13(9):. PubMed ID: 37763255
[TBL] [Abstract][Full Text] [Related]
58. Colonic clear cell adenocarcinoma with enteroblastic differentiation.
Shiratori Y; Suzuki K; Ikeya T
Clin J Gastroenterol; 2020 Dec; 13(6):1196-1199. PubMed ID: 32803644
[TBL] [Abstract][Full Text] [Related]
59. Downregulated parafibromin expression is a promising marker for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas.
Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
Virchows Arch; 2008 Feb; 452(2):147-55. PubMed ID: 18080135
[TBL] [Abstract][Full Text] [Related]
60. An analysis of clinicopathological features and prognosis by comparing hepatoid adenocarcinoma of the stomach with AFP-producing gastric cancer.
Liu X; Sheng W; Wang Y
J Surg Oncol; 2012 Sep; 106(3):299-303. PubMed ID: 22389029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
